Document is current
Any future updates will be listed below
-
Authors
Abate, Bontu
Brhane, Bokretsion Gidey
Manyazewal, Tsegahun
Mohammed, Hussien
Wuletaw, Yonas
Kassa, Moges
Hailu, Mesay
Tollera, Getachew
Tasew, Geremew
Assefa, Ashenafi
Makonnen, Eyasu
- License Information
-
More Information
Article History
Received: 7 November 2024
Accepted: 13 March 2025
First Online: 18 March 2025
Declarations
:
: Ethical approval was obtained from the Scientific and Ethics Review Committee of the Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University (Protocol number:1851/23) and the Ethiopian Public Health Institute (EPHI) (Protocol number:294/2022) IRB office prior to the study’s initiation. Permission was obtained from Shecha Health Centre. Written informed consent was obtained from each adult patient and from parent or guardian for children. Additionally, assent was obtained from children aged 12–17 years. Study details, including potential benefits and potential risks, were thoroughly explained to study participants before enrollment. Confidentiality was maintained, and participants were informed of their right to withdraw from the study at any time.
: Not applicable.
: The authors declare no competing interests.
